EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 -0.0038
March 31, 2026 -0.0046
December 31, 2025 -0.0046
September 30, 2025 -0.0062
June 30, 2025 -0.0075
March 31, 2025 -0.0651
December 31, 2024 -0.0073
September 30, 2024 -0.0068
June 30, 2024 -0.0244
March 31, 2024 -0.0093
December 31, 2023 -0.0229
September 30, 2023 -0.0005
June 30, 2023 -0.0054
March 31, 2023 -0.0065
December 31, 2022 -0.0029
September 30, 2022 -0.0051
June 30, 2022 -0.0054
March 31, 2022 -0.004
December 31, 2021 -0.0034
September 30, 2021 -0.0065
June 30, 2021 -0.0048
March 31, 2021 -0.0045
December 31, 2020 -0.0065
September 30, 2020 -0.009
June 30, 2020 -0.0247
Date Value
March 31, 2020 -0.0207
December 31, 2019 -0.0264
September 30, 2019 -0.0263
June 30, 2019 -0.0223
March 31, 2019 -0.1158
December 31, 2018 -0.0863
September 30, 2018 -0.0202
June 30, 2018 -0.04
March 31, 2018 -0.02
December 31, 2017 0.00
September 30, 2017 -0.02
June 30, 2017 -0.02
March 31, 2017 -0.02
December 31, 2016 -0.04
September 30, 2016 -0.01
June 30, 2016 -0.01
March 31, 2016 -0.025
February 29, 2016 0.00
November 30, 2015 0.00
August 31, 2015 0.00
May 31, 2015 0.00
February 28, 2015 0.00
November 30, 2014 -0.009
August 31, 2014 -0.0112
May 31, 2014 -0.0078

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Biomerica, Inc. -0.3729
Univec, Inc. -0.0001
Lantheus Holdings, Inc. 1.111
IDEXX Laboratories, Inc. 4.267
Neogen Corp. -0.0519